GalliaPharm® Ge-68/Ga-68 generator receives approval for United Kingdom
Eckert & Ziegler Radiopharma GmbH has been granted marketing authorization (PL 46734/0001) for GalliaPharm® from the Medicines & Healthcare products Regulatory Agency (MHRA) in the United Kingdom. This important milestone makes GalliaPharm® available as a medicinal product in 13 European countries.
GalliaPharm® 68Ge/68Ga generator is a pharmaceutical product for the cyclotron-independent production of the positron emitter (68Ga) Gallium, giving a lot of flexibility when it comes to patient scheduling. 68Ga-labeled medicinal products are used in Positron Emission Tomography (PET) in the diagnosis of cancer.
The successful approval process makes GalliaPharm® the first 68Ge/68Ga generator registered as a medicinal product in the UK; thus, makes 68Ga available for use with SOMAKIT TOC® and clinical trials with [68Ga]Ga-PSMA-HBED-CC for PET diagnostics.
For more information about GalliaPharm® and its registration please contact our UK distributor Imaging Equipment Limited or fill the contact form below.